Career Development Strategies for Software Engineers in the Age of AI

When code is written in the blink of an eye, the act of producing it stops being a differentiator. The real value shifts to judgment, system design, operational reliability, and domain expertise. Here's how to structure development to excel in areas where AI doesn't give your competition an edge.

Read more

In today's flood of fragmentary information, half-truths, moderated opinions and outright lies, readers find it increasingly hard to reach reliable content, analyses and solid data. Paradoxically, the internet's unlimited access to information leads to deepening disinformation and often makes it significantly harder to assess reality correctly. Browsing today's news outlets, it is easy to get the impression that every article was written to order, that its purpose is manipulation or simply nudging the reader toward a specific action.

We never create clickbait, fake news or commercial posts to drive sales or to influence the reader's judgment and behaviour. We do not publish opinions - we value facts alone and base our analyses and articles on them. When preparing our publications, we make every effort to ensure that the content we cite is verified and substantively accurate. We make sure it is backed by external sources and analyses, by research from established institutions, independent centres or simply authorities in the given field.

We do not create ads, hidden advertising or marketing campaigns. We play clean. If our content references our own products or services, we mark it clearly. Even so, we encourage the Reader to independently verify the information that reaches them and to pursue the truth at all costs, in our increasingly computerised world.

Latest articles

Off-Label Use: When Medications Go Beyond Approved Indications

There’s a lot of misunderstanding surrounding this term. The most common misconception is that off-label use is either illegal or experimental. Neither of these descriptions is accurate. Off-label simply means that a particular use of a drug hasn’t gone through the formal registration process for that specific indication. The drug itself is approved, available on the market, and comes with official documentation. It’s just being used in a way that differs from what’s outlined in the registration

Piotr Klimaszewski
Read more

Caffeine, Theobromine, and L-Theanine: A Synergistic Trio for Focus

Discover how caffeine, theobromine, and L-theanine enhance focus, combat drowsiness, and elevate mood without the jittery side effects. Learn the mechanisms behind their action, optimal dosing, and the safety profile of combining 100 mg of caffeine with theobromine and L-theanine.

Piotr Klimaszewski
Read more
Made by

Affector by Codeenable

Affector is an editorial publication run by Codeenable, a software studio. We publish two parallel beats: one on pharmaceuticals, medicine, biology and life sciences; one on software, its architecture, AI and cloud. We chose this combination on purpose, not by accident.

About Contact

Affector writes about pharmaceuticals, medicine, biology and the life and human sciences, and also about the technical underpinnings that make these fields advance.

We publish across domains that touch both the core subjects, pharma and medicine, and the technical craft that supports them - software, its architecture, and the current dominance of cloud solutions and AI.

Both silos genuinely interest our team, and the need to integrate digital techniques into medicine, pharma and the human sciences is growing at an avalanche pace.

Without cooperation with software teams, real progress in medicine and pharma is hard to come by today, and the most ambitious engineering projects increasingly emerge in response to real problems in biology and the clinic.

Hence the long-form, sourced writing that does not flinch at code or at clinical detail, producing a unique combination that is genuinely useful to clinicians and engineers alike.